Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income taxes (Tables)

v3.23.1
Income taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The components of the net loss before the provision for income taxes for the years ended December 31, 2020, 2021 and 2022 were as follows:
December 31,
2020 2021 2022
Domestic $ (23,959) $ (69,245) $ (84,778)
Foreign 2,603  1,247  1,633 
Total loss before income taxes $ (21,356) $ (67,998) $ (83,145)
Schedule of Components of Income Tax Expense (Benefit)
The provision for income taxes for the years ended December 31, 2020, 2021 and 2022 was as follows:
December 31,
2020 2021 2022
Current:
Domestic $ —  $ 11  $ 109 
Foreign 375  569  1,933 
Total current income tax expense 375  580  2,042 
Deferred:
Domestic —  —  (24)
Foreign 265  401  (1,502)
Total deferred income tax expense 265  401  (1,526)
Total provision for income taxes $ 640  $ 981  $ 516 
Schedule of Effective Income Tax Rate Reconciliation A reconciliation of the Company’s theoretical income tax expense to actual income tax expense for the years ended December 31, 2020, 2021 and 2022 is as follows:
December 31,
2020 2021 2022
Tax Rate Tax Rate Tax Rate
Theoretical tax benefit $ (4,912) 23  % $ (15,640) 23  % $ (19,123) 23  %
Increase (decrease) in effective tax rate due to:
Change in valuation allowance 4,283  (20) 13,598  (20) 16,187  (20)
Effect of entities with different tax rates 68  125  125 
Non-deductible expenses, net 1,294  (6) 2,439  (4) 3,442  (4)
Income in zero tax rate —  % —  % (67) %
Change in tax reserve for uncertain tax positions 60  101  12 
Other (153) 358  (1) (60)
Total effective income taxes $ 640  (3) % $ 981  (2) % $ 516  (1) %
Schedule of Deferred Tax Assets and Liabilities
The following table presents the significant components of the Company’s deferred tax assets and liabilities:
December 31,
2021 2022
Deferred tax assets:
Net operating loss carryforwards $ 41,699  $ 56,542 
Research and development expenses 7,995  12,043 
Lease liabilities —  11,394 
Accruals and reserves 1,553  1,455 
Share-based compensation 669  1,231 
Issuance costs 2,368  1,184 
Deferred revenue 97  900 
Other — 
Gross deferred tax assets 54,381  84,751 
Valuation allowance (51,417) (70,818)
Total deferred tax assets $ 2,964  $ 13,933 
Deferred tax liabilities:
Intangible assets (3,342) (2,280)
Deferred contract acquisition costs (2,269) (2,785)
Property and equipment (212) (902)
Right-of-use-assets —  (9,449)
Other —  — 
Gross deferred tax liabilities (5,823) (15,416)
Net deferred taxes $ (2,859) $ (1,483)
Schedule of Unrecognized Tax Benefits Roll Forward
The following table shows the changes in the gross amount of unrecognized tax benefits as of December 31, 2020, 2021 and 2022.
Unrecognized tax
positions
Balance as of January 1, 2020 $ 242 
Increases related to current year tax positions 60 
Balance as of December 31, 2020 302 
Increases related to current year tax positions 101 
Balance as of December 31, 2021 403 
Increases related to current year tax positions 12 
Additions related to business combinations 193 
Balance as of December 31, 2022 $ 608